TACSTD2 and digestive system neoplasm: This systematic review highlights the prognostic role of TROP-2 as a biomarker for gastrointestinal tumors and emphasizes the need for the further validation of the conclusions derived from in vitro retrospective clinical studies to a more prospective and randomized in vivo setting in order to elucidate its therapeutic possibilities.